Table 3.
Summary of the haemophagocytic lymphohistiocytosis (HLH)-2004 treatment protocol (the complete protocol is available on request at http://www.histiocytesociety.org).
| Initial therapy (weeks 1–8) |
| Etoposide intravenous 150 mg/m2twice weekly for 2 weeks and then weekly |
| Dexamethasone intravenous daily 10 mg/ m2for 2 weeks, 5 mg/ m2for 2 weeks, 2·5 mg/ m2for 2 weeks, 1·25 mg/ m2for 2 weeks, tapering for 1 week |
| Cyclosporin A oral daily, aiming at trough levels of 200 µg/l |
| Intrathecal methotrexate (up to 4 doses) weeks 3–6 if there is central nervous system involvement |
| Continuation therapy (week 9 until haematopoietic stem cell transplant) |
| Etoposide 150 mg/m2every second week alternating with dexamethasone |
| Dexamethasone intravenous 10 mg/ m2× 3 days every second week |
| Cyclosporin A daily oral aiming at trough levels of 200 µg/l |
| Reactivation therapy |
| Restart from week 2 of initial therapy |